3. Epidemiologia Robert G. Nelson, MD, Katherine R. Tuttle. Clinical Practice Guidelines and Clinical Practice Recommendations for DIABETES AND CHRONIC KIDNEY DISEASE. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S10-S11
4. Definición Lesiones microangiopaticas renales Complicación vascular crónica especifica de la diabetes Alteraciones funcionales y estructurales. Proliferación de la matriz y celularidadmesangial-> aumento del grosor de la MB glomerular -> esclerosis glomerular. Robert G. Nelson, MD, Katherine R. Tuttle. Clinical Practice Guidelines and Clinical Practice Recommendations for DIABETES AND CHRONIC KIDNEY DISEASE. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S10-S11
5. Definicion Robert G. Nelson, MD, Katherine R. Tuttle. Clinical Practice Guidelines and Clinical Practice Recommendations for DIABETES AND CHRONIC KIDNEY DISEASE. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S10-S11
6. Histopatología Hipertrofia glomerular: Celularidadmesangial: Kimmelstiel-Wilson: Engrosamiento mesangial: Suma Dronavalli, Irena Duka and George L Bakris. The pathogenesis of diabetic nephropathy. nature clinical practice ENDOCRINOLOGY & METABOLISM. AUGUST 2008 vol 4 no 8
7. Fisiopatologia Suma Dronavalli, Irena Duka and George L Bakris. The pathogenesis of diabetic nephropathy. nature clinical practice ENDOCRINOLOGY & METABOLISM. AUGUST 2008 vol 4 no 8
8. Fisiopatologia Suma Dronavalli, Irena Duka and George L Bakris. The pathogenesis of diabetic nephropathy. nature clinical practice ENDOCRINOLOGY & METABOLISM. AUGUST 2008 vol 4 no 8
9. Fisiopatologia Prorrenina-> Proteincinasas activadas por mitogenos (MAPK) Citoquinas. Estrés oxidativo Susceptibilidad genetica. Suma Dronavalli, Irena Duka and George L Bakris. The pathogenesis of diabetic nephropathy. nature clinical practice ENDOCRINOLOGY & METABOLISM. AUGUST 2008 vol 4 no 8
10. Historia Natural. Richard J. MacIsaac and George Jerums. Diabetic kidney disease with and without albuminuria. CurrentOpinion in Nephrologyand Hypertension2011, 20:000–000
11. Historia Natural Richard J. MacIsaac and George Jerums. Diabetic kidney disease with and without albuminuria. CurrentOpinion in Nephrologyand Hypertension2011, 20:000–000
12. Riesgo de Muerte Robert G. Nelson, MD, Katherine R. Tuttle. Clinical Practice Guidelines and Clinical Practice Recommendations for DIABETES AND CHRONIC KIDNEY DISEASE. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S10-S11
13. Clasificación Robert G. Nelson, MD, Katherine R. Tuttle. Clinical Practice Guidelines and Clinical Practice Recommendations for DIABETES AND CHRONIC KIDNEY DISEASE. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S10-S11
15. Screening y Tratamiento Robert G. Nelson, MD, Katherine R. Tuttle. Clinical Practice Guidelines and Clinical Practice Recommendations for DIABETES AND CHRONIC KIDNEY DISEASE. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S10-S11
16. Screening y Tratamiento Robert G. Nelson, MD, Katherine R. Tuttle. Clinical Practice Guidelines and Clinical Practice Recommendations for DIABETES AND CHRONIC KIDNEY DISEASE. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S10-S11
17. Screening y Tratamiento Albuminuria: - DM tipo 1: después de 5 años del diagnostico. - DM tipo 2: en todos a partir del diagnostico. Creatinina: - En todos los diabeticos Anualmente Robert G. Nelson, MD, Katherine R. Tuttle. Clinical Practice Guidelines and Clinical Practice Recommendations for DIABETES AND CHRONIC KIDNEY DISEASE. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S10-S11
18. Tratamiento (A) Robert G. Nelson, MD, Katherine R. Tuttle. Clinical Practice Guidelines and Clinical Practice Recommendations for DIABETES AND CHRONIC KIDNEY DISEASE. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S10-S11